One-year follow-up results of a phase I trial of mycophenolate mofetil (RS61443) in cadaveric renal transplantation.
Deierhoi
M H
MH
Department of Surgery, University of Alabama, Birmingham 35294.
Sollinger
H W
HW
Diethelm
A G
AG
Belzer
F O
FO
Kauffman
R S
RS
D000328:Adult; D002102:Cadaver; D004305:Dose-Response Relationship, Drug; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000628:therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use / Q000633:toxicity*; D016030:Kidney Transplantation / Q000276:immunology*; D016853:Muromonab-CD3 / Q000627:therapeutic use; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use / Q000633:toxicity
D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D009173:Mycophenolic Acid